Roche Delves Further Into Genomics Research Market with Acquisition of NimbleGen Systems | GenomeWeb
This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
Following on its acquisition of 454 Life Sciences a few months ago, Roche this week signed a definitive agreement to acquire privately held microarray firm NimbleGen Systems for $272.5 million, which is 20 times NimbleGen’s 2006 revenues.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.